|
PPP1R15B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.66780000000677E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.63050000004483E-06 |
| Normal-vs-Stage2 |
2.902000E-03 |
| Normal-vs-Stage3 |
7.580200E-02 |
| Normal-vs-Stage4 |
5.367600E-01 |
| Stage1-vs-Stage2 |
5.139000E-01 |
| Stage1-vs-Stage3 |
2.795800E-02 |
| Stage1-vs-Stage4 |
2.544000E-01 |
| Stage2-vs-Stage3 |
2.527000E-01 |
| Stage2-vs-Stage4 |
3.965400E-01 |
| Stage3-vs-Stage4 |
7.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.67860000000509E-05 |
| Normal-vs-AfricanAmerican |
4.771500E-04 |
| Normal-vs-Asian |
1.457940E-02 |
| Caucasian-vs-AfricanAmerican |
7.482200E-01 |
| Caucasian-vs-Asian |
5.270000E-01 |
| AfricanAmerican-vs-Asian |
4.224600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.41599999997833E-06 |
| Normal-vs-Female |
6.143700E-03 |
| Male-vs-Female |
8.819800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.178600E-03 |
| Normal-vs-Extreme_Weight |
5.1258000000054E-07 |
| Normal-vs-Obese |
1.740190E-03 |
| Normal-vs-Extreme_Obese |
4.606200E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.961190E-01 |
| Normal_Weight-vs-Obese |
9.906600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.686000E-01 |
| Extreme_Weight-vs-Obese |
8.629700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.243600E-01 |
| Obese-vs-Extreme_Obese |
9.685400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.829200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.393780E-04 |
| Normal-vs-Age(61-80Yrs) |
1.87231999999593E-05 |
| Normal-vs-Age(81-100Yrs) |
1.424080E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.994500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.150000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.273900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.884600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.129600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.279200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.5255000003539E-07 |
| Normal-VS-Type2 PRCC |
8.620400E-03 |
| Normal-VS-KIRP CIMP |
8.520800E-01 |
| Normal-VS-Unclassified PRCC |
1.963940E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.832100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.584340E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.320400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.574200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.878800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.182300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58769999994524E-06 |
| Normal-vs-N1 |
7.359600E-01 |
| Normal-vs-N2 |
7.777800E-01 |
| N0-vs-N1 |
1.624380E-02 |
| N0-vs-N2 |
6.056000E-02 |
| N1-vs-N2 |
9.734200E-01 |
|
|
